Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Goodwill & Intangibles of $760.0 million for Q1 2026, down 22.98% year-over-year from $986.7 million in Q1 2025, and down 6.8% quarter-over-quarter from $815.4 million in Q4 2025.
Collegium Pharmaceutical (COLL) Goodwill & Intangibles (2016 - 2026) Analysis & Trends
Collegium Pharmaceutical's Goodwill & Intangibles history runs 11 years deep, the most recent figure standing at $760.0 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 22.98% year-over-year to $760.0 million; the TTM figure through Mar 2026 stood at $760.0 million (down 22.98% YoY), while the FY2025 annual figure was $815.4 million, down 22.61% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $760.0 million, down from $815.4 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $1.1 billion in Q1 2022, with the low at $486.5 million in Q2 2024.
- The 5-year median for Goodwill & Intangibles is $870.9 million (2025), against an average of $843.8 million.
- The sharpest annual moves came in 2022 and 2024: Goodwill & Intangibles soared 280.45% in 2022, then plunged 51.98% in 2024.
- Collegium Pharmaceutical's Goodwill & Intangibles stood at $701.2 million in 2022, then dropped by 20.77% to $555.6 million in 2023, then surged by 89.67% to $1.1 billion in 2024, then fell by 22.61% to $815.4 million in 2025, then dropped by 6.8% to $760.0 million in 2026.
- Business Quant data shows COLL's Goodwill & Intangibles at $760.0 million in Q1 2026, $815.4 million in Q4 2025, and $870.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Collegium Pharmaceutical | 892.67 Mn | 743.35 Mn | 110.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.38 Bn |
| Mar 31, 2026 | 759.96 Mn |
| Dec 31, 2025 | 815.44 Mn |
| Sep 30, 2025 | 870.91 Mn |
| Jun 30, 2025 | 928.39 Mn |
| Mar 31, 2025 | 986.69 Mn |
| Dec 31, 2024 | 1.05 Bn |
| Sep 30, 2024 | 1.09 Bn |
| Jun 30, 2024 | 486.53 Mn |
| Mar 31, 2024 | 521.05 Mn |
| Dec 31, 2023 | 555.57 Mn |
| Sep 30, 2023 | 590.08 Mn |
| Jun 30, 2023 | 626.40 Mn |
| Mar 31, 2023 | 1.09 Bn |
| Dec 31, 2022 | 701.16 Mn |
| Sep 30, 2022 | 1.09 Bn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 1.10 Bn |
| Dec 31, 2021 | 268.72 Mn |
| Sep 30, 2021 | 285.52 Mn |